Study design to evaluate a group-based therapy for support persons of adults on buprenorphine/naloxone

Karen Chan Osilla, Kirsten Becker, Liisa Ecola, Brian Hurley, Jennifer K Manuel, Allison Ober, Susan M Paddock, Katherine E Watkins, Karen Chan Osilla, Kirsten Becker, Liisa Ecola, Brian Hurley, Jennifer K Manuel, Allison Ober, Susan M Paddock, Katherine E Watkins

Abstract

Background: Opioid use disorders (OUDs) have devastating effects on individuals, families, and communities. While medication treatments for OUD save lives and are increasingly utilized, rates of treatment dropout are very high. In addition, most existing medication treatments for OUD may often neglect the impact of untreated OUD on relationships and ignore the potential role support persons (SPs) could have on encouraging long-term recovery, which can also impact patient treatment retention.

Methods/design: The current study adapts Community Reinforcement and Family Training (CRAFT) for use with SPs (family member, spouse or friend) of patients using buprenorphine/naloxone (buprenorphine) in an outpatient community clinic setting. The study will evaluate whether the adapted intervention, also known as integrating support persons into recovery (INSPIRE), is effective in increasing patient retention on buprenorphine when compared to usual care. We will utilize a two-group randomized design where patients starting or restarting buprenorphine will be screened for support person status and recruited with their support person if eligible. Support persons will be randomly assigned to the INSPIRE intervention, which will consist of 10 rolling group sessions led by two facilitators. Patients and SPs will each be assessed at baseline, 3 months post-baseline, and 12 months post-baseline. Patient electronic medical record data will be collected at six and 12 months post-baseline. We will examine mechanisms of intervention effectiveness and also conduct pre/post-implementation surveys with clinic staff to assess issues that would affect sustainability.

Discussion: Incorporating the patient's support system may be an important way to improve treatment retention in medication treatments for OUD. If SPs can serve to support patient retention, this study would significantly advance work to help support the delivery of effective treatments that prevent the devastating consequences associated with OUD. Trial registration This study was registered with ClinicalTrials.gov, NCT04239235. Registered 27 January 2020, https://ichgcp.net/clinical-trials-registry/NCT04239235 .

Keywords: Buprenorphine; CRAFT; Family; Medication assisted treatment; Opioid use disorders.

Conflict of interest statement

The authors declare that they have no competing interests.

Figures

Fig. 1
Fig. 1
Core functions of CRFAT
Fig. 2
Fig. 2
Study flow
Fig. 3
Fig. 3
Study flow

References

    1. American Psychiatric Association . Diagnostic and statistical manual of mental disorders. Washington, DC: American Psychiatric Association; 2013.
    1. Daley D, Smith E, Balogh D, Toscaloni J. Forgotten but not gone: the impact of the opioid epidemic and other substance use disorders on families and children. Commonwealth. 2018;20:2–3.
    1. Weisner C, Parthasarathy S, Moore C, Mertens JR. Individuals receiving addiction treatment: are medical costs of their family members reduced? Addiction. 2010;105(7):1226–1234.
    1. Secretary Price Announces HHS strategy for fighting opioid crisis [press release]. Atlanta, GA: U.S. Department of Health and Human Services. 2017.
    1. Weinstein ZM, Kim HW, Cheng DM, Quinn E, Hui D, Labelle CT, et al. Long-term retention in office based opioid treatment with buprenorphine. J Subst Abuse Treat. 2017;74:65–70.
    1. Soeffing JM, Martin LD, Fingerhood MI, Jasinski DR, Rastegar DA. Buprenorphine maintenance treatment in a primary care setting: outcomes at 1 year. J Subst Abuse Treat. 2009;37(4):426–430.
    1. Simon CB, Tsui JI, Merrill JO, Adwell A, Tamru E, Klein JW. Linking patients with buprenorphine treatment in primary care: predictors of engagement. Drug Alcohol Depend. 2017;181:58–62.
    1. Brigham GS, Slesnick N, Winhusen TM, Lewis DF, Guo X, Somoza E. A randomized pilot clinical trial to evaluate the efficacy of Community Reinforcement and Family Training for Treatment Retention (CRAFT-T) for improving outcomes for patients completing opioid detoxification. Drug Alcohol Depend. 2014;138:240–243.
    1. Kaufmann M. Recognizing the signs and symptoms of distress. Ontario Med Rev. 1999;66(5):46–47.
    1. Sobell MB, Sobell LC. Problem drinkers: guided self-change treatment. New York: Guilford Press; 1993.
    1. Halford WK, Osgarby SM. Alcohol abuse clients presenting with marital problems. J Fam Psychol. 1993;6:245–254.
    1. Thomas EJ, Agar RD. Unilateral family therapy with the spouses of uncooperative alcohol abusers. In: O’Farrell TJ, editor. Treating alcohol problems: marital and family interventions. New York: Guilford Press; 1993. pp. 3–33.
    1. Stuart RB. Operant-interpersonal treatment for marital discord. J Consult Clin Psychol. 1969;33(6):675–682.
    1. Weiss RL, Hops H, Patterson GR. A framework for conceptualizing marital conflict: a technology for altering it, some data for evaluating it. In: Handy LD, EJ Mash, editors. Behavior change: methodology, concepts, and practice champaign. Champaign: Research Press; 1973. pp. 309–342.
    1. National Institute on Drug Abuse. Medications to treat opioid use disorder 2018.
    1. Meyers RJ, Wolfe BL. Get your loved one sober: alternatives to nagging, pleading and threatening. Center City: Hazelden; 2004.
    1. Smith JE, Meyers RJ. Motivating substance abusers to enter treatment: working with family members. 1. New York: The Guilford Press; 2007.
    1. SAMHSA. Community Reinforcement and Family Training (CRAFT) Intervention Summary 2013. .
    1. Kirby KC, Versek B, Kerwin ME, Meyers K, Benishek LA, Bresani E, et al. Developing Community Reinforcement and Family Training (CRAFT) for parents of treatment-resistant adolescents. J Child Adolesc Subst Abuse. 2015;24(3):155–165.
    1. Manuel JK, Austin JL, Miller WR, McCrady BS, Tonigan JS, Meyers RJ, et al. Community Reinforcement and Family Training: a pilot comparison of group and self-directed delivery. J Subst Abuse Treat. 2012;43(1):129–136.
    1. Meyers RJ, Miller WR, Smith JE, Tonigan JS. A randomized trial of two methods for engaging treatment-refusing drug users through concerned significant others. J Consult Clin Psychol. 2002;70(5):1182–1185.
    1. Miller WR, Meyers RJ, Tonigan JS. Engaging the unmotivated in treatment for alcohol problems: a comparison of three strategies for intervention through family members. J Consult Clin Psychol. 1999;67(5):688–697.
    1. Roozen HG, de Waart R, van der Kroft P. Community reinforcement and family training: an effective option to engage treatment-resistant substance-abusing individuals in treatment. Addiction. 2010;105(10):1729–1738.
    1. Waldron HB, Kern-Jones S, Turner CW, Peterson TR, Ozechowski TJ. Engaging resistant adolescents in drug abuse treatment. J Subst Abuse Treat. 2007;32(2):133–142.
    1. Osilla KC, Pedersen ER, Tolpadi A, Howard SS, Phillips JL, Gore KL. The feasibility of a web-intervention for military veteran spouses concerned about their partner’s alcohol misuse. J Behav Health Serv Res. 2018;45(1):57–73.
    1. Osilla KC, Trail TE, Pedersen ER, Gore KL, Tolpadi A, Rodriguez LM. Efficacy of a web-based intervention for concerned spouses of service members and veterans with alcohol misuse. J Marit Fam Ther. 2017;44:292–306.
    1. Rodriguez LM, Neighbors C, Osilla KC, Trail TE. The longitudinal effects of military spouses’ concern and behaviors over partner drinking on relationship functioning. Alcohol. 2019;76:29–36. doi: 10.1016/j.alcohol.2018.07.004.
    1. Rodriguez LM, Osilla KC, Trail TE, Gore KL, Pedersen ER. Alcohol use among concerned partners of heavy drinking service members and veterans. J Marit Fam Ther. 2017;44(2):277–291.
    1. Pedersen E, Osilla K, Hemluth E, Tolpadi A, Gore K. Reaching concerned partners of heavy drinking service members and veterans through Facebook. Milit Behav Health. 2017;5(3):265–273.
    1. Jones CM. The paradox of decreasing nonmedical opioid analgesic use and increasing abuse or dependence—an assessment of demographic and substance use trends, United States, 2003–2014. Addict Behav. 2017;65:229–235.
    1. Saha TD, Kerridge BT, Goldstein RB, Chou SP, Zhang H, Jung J, et al. Nonmedical prescription opioid use and DSM-5 nonmedical prescription opioid use disorder in the United States. J Clin Psychiatry. 2016;77(6):772–780.
    1. Wu LT, Zhu H, Swartz MS. Treatment utilization among persons with opioid use disorder in the United States. Drug Alcohol Depend. 2016;169:117–127.
    1. Hser YI, Saxon AJ, Huang D, Hasson A, Thomas C, Hillhouse M, et al. Treatment retention among patients randomized to buprenorphine/naloxone compared to methadone in a multi-site trial. Addiction. 2014;109(1):79–87.
    1. Miranda J, Azocar F, Organista KC, Dwyer E, Areane P. Treatment of depression among impoverished primary care patients from ethnic minority groups. Psychiatr Serv. 2003;54(2):219–225.
    1. Kuneman ES. Enhancing group cognitive behavioral therapy for Hispanic/Latino clients with depression: Recommendations for culturally sensitive practice. Psychology Dissertations. 2010. Paper 77. .
    1. Aguilera A, Garza MJ, Munoz RF. Group cognitive-behavioral therapy for depression in Spanish: culture-sensitive manualized treatment in practice. J Clin Psychol. 2010;66(8):857–867.
    1. González-Prendes AA, Hindo C, Pardo Y. Cultural values integration in cognitive-behavioral therapy for a Latino with depression. Clin Case Stud. 2011;10(5):376–394.
    1. Miranda J, Bernal G, Lau A, Kohn L, Hwang WC, LaFromboise T. State of the science on psychosocial interventions for ethnic minorities. Annu Rev Clin Psychol. 2005;1:113–142.
    1. Wells K, Sherbourne C, Schoenbaum M, Ettner S, Duan N, Miranda J, et al. Five-year impact of quality improvement for depression: results of a group-level randomized controlled trial. Arch Gen Psychiatry. 2004;61(4):378–386.
    1. Barrera M, Castro FG. A heuristic framework for the cultural adaptation of interventions. Clin Psychol Sci Pract. 2006;13(4):311–316.
    1. Strauss AC, Corbin J. Basics of qualitative research: techniques and procedures for developing grounded theory. Thousand Oaks: Sage Publications, Inc.; 1998.
    1. Krippendorf K. Content analysis: An introduction to its methodology. Beverly Hills: Sage Publications; 1980.
    1. Weber RP. Basic content analysis. Newbury Park: Sage Publications, Inc.; 1990.
    1. Rogers E. Diffusion of innovations. 4. New York: The Free Press; 1995.
    1. Weiner BJ, Lewis MA, Linnan LA. Using organization theory to understand the determinants of effective implementation of worksite health promotion programs. Health Educ Res. 2009;24(2):292–305.
    1. Chappel JN, Veach TL, Krug RS. The substance abuse attitude survey: an instrument for measuring attitudes. J Stud Alcohol. 1985;46(1):48–52.
    1. Friedmann PD, Hoskinson R, Gordon M, Schwartz R, Kinlock T, Knight K, et al. Medication-assisted treatment in criminal justice agencies affiliated with the criminal justice-drug abuse treatment studies (CJ-DATS): availability, barriers, and intentions. Subst Abuse. 2012;33(1):9–18.
    1. Pew Research Center. Collecting Survey Data. 2016.
    1. Ober AJ, Watkins KE, Hunter SB, Ewing B, Lamp K, Lind M, et al. Assessing and improving organizational readiness to implement substance use disorder treatment in primary care: findings from the SUMMIT study. BMC Fam Pract. 2017;18(1):107.
    1. University of New Mexico. IMPORTANT PEOPLE Initial Interview (IPI) 2006. .
    1. National Quality Forum . Behavioral Health 2016–2017. Washington, DC: National Quality Forum; 2017.
    1. Watkins KE, Pincus HA, Paddock S, Smith B, Woodroffe A, Farmer C, et al. Care for veterans with mental and substance use disorders: good performance, but room to improve on many measures. Health Aff. 2011;30(11):2194–2203.
    1. Pocock S. Clinical Trials: A practical approach. Chichester: Wiley; 1984.
    1. Osilla KC, Watkins KE, D’Amico EJ, McCullough CM, Ober AJ. Effects of motivational interviewing fidelity on substance use treatment engagement in primary care. J Subst Abuse Treat. 2018;87:64–69.
    1. Osilla KC, Paddock SM, McCullough CM, Jonsson L, Watkins KE. Randomized clinical trial examining cognitive behavioral therapy for individuals with a first-time DUI offense. Alcohol Clin Exp Res. 2019;43(10):2222–2231.
    1. Nordstrom BR, Saunders EC, McLeman B, Meier A, Xie H, Lambert-Harris C, et al. Using a learning collaborative strategy with office-based practices to increase access and improve quality of care for patients with opioid use disorders. J Addict Med. 2016;10(2):117–123.
    1. Center for Behavioral Health Statistics and Quality . 2018 National Survey on Drug Use and Health (NSDUH): CAI Specifications for Programming (English Version) Rockville: Substance Abuse and Mental Health Services Administration; 2017.
    1. Ehrman RN, Robbins SJ. Reliability and validity of 6-month timeline reports of cocaine and heroin use in a methadone population. J Consult Clin Psychol. 1994;62(4):843–850.
    1. Fals-Stewart W, O’Farrell TJ, Freitas TT, McFarlin SK, Rutigliano P. The timeline followback reports of psychoactive substance use by drug-abusing patients: psychometric properties. J Consult Clin Psychol. 2000;68(1):134–144.
    1. Bohnert ASB, Bonar EE, Cunningham R, Greenwald MK, Thomas L, Chermack S, et al. A pilot randomized clinical trial of an intervention to reduce overdose risk behaviors among emergency department patients at risk for prescription opioid overdose. Drug Alcohol Depend. 2016;163:40–47.
    1. Sheehan DV. Sheehan Disability Scale (SDS)—overview. 1983.
    1. Olson DH, Gorall DM, Tiesal JW. FACES IV Package: Administration Manual. Life Innovations. 2006.
    1. Center for Behavioral Health Statistics and Quality . 2014 Natuibak Syrvet ib drug use and health: methodological summary and definitions. Rockville: Substance Abuse and Mental Health Services Administration; 2015.
    1. Attkisson CC, Zwick R. The client satisfaction questionnaire. Psychometric properties and correlations with service utilization and psychotherapy outcome. Eval Program Plann. 1982;5(3):233–237.
    1. Alford DP, LaBelle CT, Kretsch N, Bergeron A, Winter M, Botticelli M, et al. Collaborative care of opioid-addicted patients in primary care using buprenorphine five-year experience. Archiv Intern Med. 2011;171(5):425–431.
    1. Benjamini Y, Hochberg Y. Controlling the false discovery rate—a practical and powerful approach to multiple testing. J R Stat Soc B. 1995;57(1):289–300.
    1. Kahan BC, Morris TP. Reporting and analysis of trials using stratified randomisation in leading medical journals: review and reanalysis. BMJ. 2012;345:e5840.

Source: PubMed

Sponsorer og samarbejdspartnere

Medicinske tilstande

Narkotikainterventioner

3
Abonner